Literature DB >> 11088082

Risk factors for the rising rates of primary liver cancer in the United States.

H B El-Serag1, A C Mason.   

Abstract

BACKGROUND: A recent increase in the incidence of hepatocellular carcinoma was reported in the United States. The cause of this witnessed rise remains unknown.
METHODS: We examined the temporal changes in both age-specific and age-standardized hospitalization rates of primary liver cancer associated with hepatitis C, hepatitis B, and alcoholic cirrhosis in the Department of Veterans Affairs Medical Center's Patient Treatment File.
RESULTS: A total of 1605 patients were diagnosed with primary liver cancer between 1993 and 1998. The overall age-adjusted proportional hospitalization rate for primary liver cancer increased from 36.4 per 100,000 (95% confidence interval [CI], 34.0-38.9) between 1993 and 1995 to 47.5 per 100,000 (95% CI, 44.6-50.1) between 1996 and 1998. There was a 3-fold increase in the age-adjusted rates for primary liver cancer associated with hepatitis C virus, from 2.3 per 100,000 (95% CI, 1. 8-3.0) between 1993 and 1995 to 7.0 per 100,000 (95% CI, 5.9-8.1) between 1996 and 1998. Concomitant with this rise, the age-specific rates for primary liver cancer associated with hepatitis C also shifted toward younger patients. During the same periods, the age-adjusted rates for primary liver cancer associated with either hepatitis B virus (2.2 vs 3.1 per 100,000) or alcoholic cirrhosis (8. 4 vs 9.1 per 100,000) remained stable. The rates for primary liver cancer without risk factors also remained without a statistically significant change, from 17.5 (95% CI, 15.8-19.1) between 1993 and 1995 to 19.0 per 100,000 (95% CI, 17.3-20.7) between 1996 and 1998.
CONCLUSIONS: Hepatitis C virus infection accounts for most of the increase in the number of cases of primary liver cancer among US veterans. The rates of primary liver cancer associated with alcoholic cirrhosis and hepatitis B virus infection have remained stable. Arch Intern Med. 2000;160:3227-3230.

Entities:  

Mesh:

Year:  2000        PMID: 11088082     DOI: 10.1001/archinte.160.21.3227

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  102 in total

1.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Authors:  Xuetian Yue; Zhenyu Zhang; Xiaohong Liang; Lifen Gao; Xiaoning Zhang; Di Zhao; Xiao Liu; Hongxin Ma; Min Guo; Brett T Spear; Yaoqin Gong; Chunhong Ma
Journal:  Gastroenterology       Date:  2012-03-06       Impact factor: 22.682

2.  Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.

Authors:  Ming-De Huang; Xiao-Fei Chen; Gang Xu; Qing-Quan Wu; Jian-Huai Zhang; Guo-Feng Chen; Yong Cai; Fu-Zhen Qi
Journal:  DNA Cell Biol       Date:  2011-11-09       Impact factor: 3.311

3.  The prevalence of hepatitis C virus infection in Texas: implications for future health care.

Authors:  Kanthi Yalamanchili; Sherif Saadeh; Rita Lepe; Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

4.  A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective.

Authors:  Sarah E Post; Neetu Khurana Sodhi; Chia-Hui Peng; Kejia Wan; Henry J Pollack
Journal:  Health Aff (Millwood)       Date:  2011-02       Impact factor: 6.301

5.  Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.

Authors:  Nimzing G Ladep; Shahid A Khan; Mary Me Crossey; Andrew V Thillainayagam; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma.

Authors:  Jawad Ahmad; John Rhee; Brian I Carr
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

7.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

8.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

Authors:  J A Davila; R O Morgan; Y Shaib; K A McGlynn; H B El-Serag
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

9.  Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors.

Authors:  Edward Leen; Senthil Kumar; Shahid A Khan; Gavin Low; Keh Oon Ong; Paul Tait; Mike Averkiou
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 10.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.